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E-mail address: aigaki-toshiro@tmu.ac.jp (T. AigakInsulin-degrading enzyme (IDE) is implicated in the pathogenesis of type 2 diabetes mellitus (DM2)
and Alzheimer’s disease (AD). Here we provide genetic evidence that Drosophila Ide (dIde) antago-
nizes the insulin signaling pathway and human Ab-induced neurotoxicity in Drosophila. In this
study, we also generated a dIde knockout mutant (dIdeKO) by gene targeting, and found that loss
of IDE increases the content of the major insect blood sugar, trehalose, thus suggesting a conserved
role of IDE in sugar metabolism. Using dIdeKO as a model, further investigations into the biological
functions of IDE and its role in the pathogenesis of DM2 and AD can be made.
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Insulin is an evolutionally conserved peptide hormone that is
secreted from the pancreas and promotes glucose uptake in muscle
and adipose tissue. Insulin also stimulates cell growth and differ-
entiation, and promotes the storage of glucose and lipids by stim-
ulating amino acid uptake, protein synthesis, glycogenesis, and
lipogenesis [1]. On the other hand, insulin inhibits gluconeogenesis
in the liver, which reduces blood glucose concentration. Patients
with type 2 diabetes mellitus (DM2) show insulin resistance and
defects in insulin secretion from the pancreas [2]. Although the
pathogenic mechanism of DM2 is presently unclear, insulin resis-
tance is thought to be an essential causative factor [3].
Alzheimer’s disease (AD) is often associated with DM2 [4]. The
risk of developing AD increases 1.6-fold in patients with DM2 [5].
Brains of AD patients exhibit neurodegeneration, neuronal cell
death, and tissue atrophies. It has been suggested that AD-linked
neurodegeneration is caused by an accumulation of b-amyloid
peptide (Ab) [6]. Both amyloid plaque and soluble Ab oligomers
are thought to have neurotoxic effects that promote neuroﬁbrillarychemical Societies. Published by E
2, type 2 diabetes mellitus;
rat, Goto-Kakizaki rat; dilp2,
tor; Ab, b-amyloid; APP, Ab
me; AICD, APP intracellular
i).tangle formation [7]. In patients with late-onset AD (LOAD), pep-
tide clearance can be impaired, which results in cerebral Ab accu-
mulation [8].
Insulin-degrading enzyme (IDE), a zinc metalloendopeptidase,
has been identiﬁed as a candidate gene for diabetes susceptibility
in the Goto-Kakizaki (GK) rat, a genetic model of non-insulin-
dependent diabetes [9]. The GK allele of IDE has been regarded
as a partial loss-of-function mutation, since it has two amino acid
substitutions that reduce insulin-degrading activity by 31% [9]. In
humans, genome-wide association studies reveal that the IDE re-
gion of chromosome 10q contains a variant that confers DM2 risk
[10]. Interestingly, four markers near or in the IDE locus are asso-
ciated with AD in LOAD families [11], and catalytic activity and
expression of IDE are found to be reduced in LOAD patients [12].
Indeed, deletion of IDE in mice has been shown to cause accumu-
lation of cerebral Ab, hyperinsulinemia, and glucose intolerance
[13]. Furthermore, impaired Ab catabolism has also been observed
in primary cultured ﬁbroblasts and neurons derived from GK rats
[14]. These studies strongly support the notion that IDE is involved
in the pathogenesis of both DM2 and AD.
IDE is highly conserved from yeast to human. Drosophila IDE
shows 44% identity and 59% similarity in amino acid sequence to
that of human IDE (hIDE). Drosophila Ide (dIde) has physical and ki-
netic properties very similar to those of hIDE, including molecular
weight, optimal pH for activity, and the ability to degrade insulin
in vitro [15,16]. However, it is not clear whether dIde regulates
the insulin signal and AD-related phenotypes in vivo. Here, welsevier B.V. All rights reserved.
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Fig. 1. Functional relationship between IDE and the insulin signaling pathway.
Body weight of ﬂies overexpressing dIde, hIDE, and GFP (control) using dilp2-GAL4
(A). Effects of forced expression of dIde (upper panel) or hIDE (lower panel) on wing
size (B). sd-GAL4 was used as a driver. Superimposed images of the wings
overexpressing IDE (magenta) and the control wings expressing GFP (green).
Genetic interaction between dIde and the components of the insulin pathway. dIde
or GFP were ectopically expressed together with dilp2 or InR in developing wing
imaginal discs using sd-GAL4 (C), or in combination with the PTEN mutation (D).
Bars indicate the mean body weight or the mean wing size ±S.E. The t-test was used
to evaluate the differences in means between two groups (NS: not signiﬁcant,
*P < 0.05, and **P < 0.001).
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like peptide 2 (dilp2) signaling and the neurotoxicity that is induced
by ectopically expressed human Ab in Drosophila. In addition, we
generated a dIde null mutant and found that dIde is involved in
blood sugar homeostasis, suggesting that the function of IDE is
conserved between mammals and Drosophila.
2. Materials and methods
2.1. Fly strains
y w67c23 Df(1)w67c23 was used as a recipient for transgenic ﬂies.
elav-Gal4, GMR-Gal4, sd-Gal4, and UAS-InR were obtained from
Bloomington Stock Center. Act5C-GAL4 and UAS-mCD8::GFP were
from Kyoto Stock Center. dilp2-Gal4 [17] and UAS-dilp2 [18] were
gifts from Dr. E. Hafen. P{70FLP} P{70I-SceI} and P{70FLP}10 were
gifts from Dr. J.J. Sekelsky [19]. UAS-APP and UAS-BACE were gifts
from Dr. R. Reifegerste [20]. PTEN was a gift from Dr. D. Pan [21].
Transgenic ﬂies carrying UAS-dIde, UAS-hIDE, were generated by
P-element-mediated transformation [22]. cDNAs corresponding
to the coding regions of dIde and hIDE were obtained by RT-PCR
using mRNAs isolated from adult Drosophila and human HEK293
cells, respectively, and subcloned into the pUAST vector [23]. Gene
targeting was performed as described previously [24,25]. For con-
structing the P{donor} plasmid for gene targeting, approximately
3 kb of both upstream and downstream regions of the Ide locus
were ampliﬁed by PCR with the following primers: ideTg55XhoI:
50-CTCGAGTCTGAAAACGCCTGATCCC-30, ideTg53NheI: 50-GCTAG
C-GCGCCAGTTTCAGGTTCT-30, ideTg35NotI: 50-GCGGCCGCGAGAA
AC-GTTTTGACATCC-30, and ideTg33SmaI: 50-CCCGGGAACTTAGATA
CTGGCTATGCG-30. The sequences of PCR-ampliﬁed fragments were
conﬁrmed, and subcloned into the polylinker of p{EndsOut2} (a gift
from J.J. Sekelsky). The mini-white gene was inserted between the
upstream and downstream target sequences as a marker for trans-
formation. Targeted lines were backcrossed to the y w67c23
Df(1)w67c23 stock for six generations.
2.2. Measurement of body weight and wing size
Flies were weighed using an Analytical Semi-Micro Balance
(A&D Company, Tokyo, Japan). To measure wing size, the wings
were mounted in a drop of FLY LINE DRESSING (TIEMCO, Tokyo,
Japan). Wing images were captured using a Leica MZ16F stereo-
scopic microscope equipped with a CCD camera. Wing area was
measured using the Object-Image Program (Image J 1.41).
2.3. Cryostat section
Fly heads were ﬁxed in 2% formaldehyde/PBT (0.2% Tween-20)
for 120 min at 4 C. After washing in PBT, the tissues were incu-
bated in 12% sucrose/PBT overnight at 4 C. The tissues were im-
mersed in a drop of O.C.T. Tissue Tek Compound (Miles Inc.,
Elkhart, IN, USA) in 96 well plates, and frozen in liquid nitrogen.
The samples were cut into 10-lm sections using a cryostat. The
sections were immediately ﬁxed in 0.5% formaldehyde/PBS for
60 min at RT. The slides were washed in PBS and incubated with
rhodamine-phalloidin (Invitrogen)/PBS (1/1000) overnight at 4 C
in a moist chamber. The samples were washed in PBS, mounted
in GEL/MOUNT (Cosmo Bio, Tokyo, Japan), and observed under a
ﬂuorescence microscope (Olympus BX50).
2.4. Longevity
Longevity was determined as described previously [26]. Newly
eclosed ﬂies were collected within 24 h, they were transferred
every 2–3 days into fresh food vials until all ﬂies had died, andthe number of dead ﬂies was counted at the time of each transfer.
Twenty ﬂies were kept in a glass vial at 25 C and at least 100 ﬂies
were used for each genotype.
2.5. Glucose and trehalose measurement
Hemolymph was collected from either 25 female or 40 male
ﬂies. Flies were punctured in the thorax with a ﬁne needle and
put into 0.5-ml tubes whose bottoms had been punctured with a
22-gauge needle (Terumo, Tokyo, Japan) and plugged with cotton.
The tubes were set into 1.5-ml tubes and centrifuged at 2600g for
5 min at 4 C. The hemolymph was heated at 95 C for 5 min. Glu-
cose concentration was measured using a Glucose Assay Kit (Sig-
ma). Trehalose in the hemolymph was determined after digesting
in glucose and incubating with 0.5 U trehalase (Sigma) at 37 C
for 12 h.
3. Results and discussion
3.1. Overexpression of dIde or hIDE antagonizes insulin-dependent
tissue growth
To investigate the function of Drosophila Ide (dIde), we gener-
ated transgenic ﬂies bearing UAS-dIde that is induced upon GAL4
2918 M. Tsuda et al. / FEBS Letters 584 (2010) 2916–2920activation. We also generated UAS-human IDE (hIDE) transgenic
ﬂies to compare the functions with those bearing UAS-dIde. Since
insulin promotes protein synthesis, cell growth and proliferation,
we examined the effects of dIde overexpression on body size. When
dIde or hIDE were misexpressed in insulin producing cells using
dilp2-GAL4 as a driver, the body weight of the adult ﬂies was re-
duced to 92% and 94% of control ﬂies, respectively (Fig. 1A). We
also tested wing size, which is suitable for quantitative analysis
of tissue growth. Forced expression of either dIde or hIDE was in-
duced in the developing wing imaginal discs using sd-GAL4. We
found that wing size was signiﬁcantly reduced in these ﬂies: 82%
and 83% of the control, respectively (Fig. 1B). These results indicate
that both dIde and hIDE negatively regulate tissue growth.
Next we investigated the functional relationship between dIde
and the insulin signaling pathway more speciﬁcally. Drosophila
insulin-like peptide 2 (dilp2) promotes tissue growth [18]. Misex-
pression of dilp2 in developing wing imaginal discs produces adult
ﬂies with a wing size larger than that of control. We found that this
phenotype is suppressed signiﬁcantly when dilp2 is co-expressed
with dIde, suggesting that dIde inhibits dilp2-induced growth
(Fig. 1C). dilp2 promotes growth through the insulin receptor (InR)
[18]. Overexpression of InR in the wing imaginal disc also increases
wing size. However, unlike those induced by dilp2, the InR-induced
phenotype is not suppressed by co-overexpression of dIde, suggest-
ing that dIde acts upstream of InR (Fig. 1C). We also determined the
genetic interaction between dIde and PTEN, which functions down-
stream of InR to negatively regulate the insulin signal by inhibiting
PI3K activity. Loss-of-function mutations in PTEN increase body
size by elevating PI3K activity [27]. We found that overexpression
of dIde had no effect on the large wing phenotype caused by the
PTEN mutation (Fig. 1D). These genetic experiments strongly sug-
gest that dIde negatively regulates the insulin signaling pathway,
most likely by functioning between the Dilp2 ligand and InR.D
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Fig. 2. Overexpression of IDE in the Drosophila ADmodel. Cryostat sections of photorecep
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compared to the control, which expresses GFP by 7% and 10%, respectively. The log lank3.2. Overexpression of dIde or hIDE reduces Ab-induced neurotoxicity
It has been shown that human IDE is capable of digesting both
b-amyloid (Ab) and the Ab precursor protein (APP) intracellular do-
main (AICD) in vitro. To examine whether overexpression of dIde
can suppress the neurotoxicity induced by Ab in vivo, we used
the Drosophila AD model, in which human APP and the b-site
APP-cleaving enzyme (BACE) are misexpressed in photoreceptor
neurons [20]. In this model, a highly organized architecture of ret-
inal photoreceptors degenerates in an age-dependent manner
(Fig. 2A). We found that forced expression of dIde or hIDE can sup-
press neuronal degeneration in this model. It has been reported
that ubiquitous overexpression of APP and BACE using Act5C-
GAL4 causes ectopic wing vein formation [20]. In this study, the ec-
topic wing vein phenotype was also suppressed by forced expres-
sion of either dIde or hIDE (Fig. 2B). In addition, we found that pan-
neural overexpression of APP and BACE using elav-GAL4 shortens
the longevity of adult ﬂies: the average lifespan of elav > APP BACE
and control ﬂies (elav > GFP) was 49.3 ± 1.2 and 58.9 ± 1.3 days,
respectively (Fig. 2C and D). The reduced lifespan was partially res-
cued by forced expression of dIde or hIDE: the average lifespan was
52.9 ± 1.2 and 54.4 ± 3.0 days, respectively (Fig. 2C and D). These
results suggest that dIde or hIDE can inhibit the pathological pro-
cesses associated with Ab and/or AICD accumulation in vivo. Taken
together with these ﬁndings, the Drosophila AD model might be
useful to evaluate single nucleotide polymorphisms (SNPs) within
the coding regions of APP and IDE in humans.
3.3. Generation and phenotypic characterization of the dIde knockout
mutant
To gain insight into the role of dIde in Drosophila, we generated a
dIde knockout mutant (dIdeKO) by gene targeting. In this mutant,t>GFP act>APP, BACE,GFP
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M. Tsuda et al. / FEBS Letters 584 (2010) 2916–2920 2919the Drosophila mini-white gene replaces part of its genomic region
(exons 9 and 10) (Fig. 3A). The targeting event was conﬁrmed by
genomic PCR analysis (Fig. 3B). Since mutated dIde lacks its sub-
strate-binding domains, dIdeKO ﬂies are thought to be null. Flies
homozygous for dIdeKO were found to be viable and fertile with
no obvious developmental defects. No signiﬁcant difference was
observed in mean body weight between dIdeKO and wild type
(Fig. 4A). In mice, knockout of IDE results in hyperinsulinemia,
chronic elevation of insulin due to the reduction of insulin-degra-
dation, and glucose intolerance, which are all hallmarks of DM2
[13]. To investigate whether dIdeKO ﬂies have defects in glucose
homeostasis, we measured the concentration of glucose and treha-
lose, the insect blood sugar, in the hemolymph of dIdeKO ﬂies. We
found no signiﬁcant difference in glucose concentration between
dIdeKO and wild type, but the trehalose level in dIdeKO ﬂies in-
creased by 86% compared to that of the wild type (Fig. 4B). We
measured the longevity of dIdeKO ﬂies, and found that the mutant
ﬂies live longer (56.2 ± 1.2 and 63.8 ± 0.6 days for males and fe-Bo
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Fig. 4. Phenotypic characterization of the dIde knockout mutant. Comparison of
body weight (A) and blood sugar content (B) between dIdeKO and wild type ﬂies.
Bars indicate the mean values (±S.E.) of body weight (A) and each sugar content (B).
Statistical signiﬁcance (t-test): NS: not signiﬁcant, *P < 0.01. Survival curves of
dIdeKO and wild type ﬂies (C). dIdeKO ﬂies live longer than wild type ﬂies for both
sexes (log lank test, P < 0.001).males, respectively) when compared to wild type (53.2 ± 1.0 days
for males and 57.3 ± 1.0 days for females) (Fig. 4C). The mechanism
of longevity extension by dldeKO is currently unknown, but dIde
might affect the regulation of energy metabolism. Although the
majority of insulin degradation by IDE takes place in endosomes
and cytosol, and at the plasma membrane, IDE is also found in
mitochondria [15,28]. IDE that is localized in mitochondria appears
to bind SIRT4, which inactivates glutamate dehydrogenase (GDH)
through ADP-ribosylation [29]. Since GDH catalyzes the conversion
of glutamate to a-ketoglutarate to fuel the tricarboxylic acid cycle,
the absence of IDE might result in an alteration of energy supply
from the amino acids. The function of IDE other than insulin-deg-
radation is not well understood. Drosophila dIde knockout mutants
are a useful model system to further investigate the role of IDE in
the regulation of longevity and the pathological process of AD and
DM2.
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